Literature DB >> 11219246

Testing for antiphospholipid antibodies: problems and solutions.

S S Pierangeli1, A E Gharavi, E N Harris.   

Abstract

The first aCL test was developed in 1983 and subsequently standardized. Although new and more specific tests have become available, the aCL ELISA and the LA tests are still the first choice to be used in diagnosis of APS. Newer tests such as the anti beta 2 GP1 ELISA and the APhL ELISA Kit (Louisville APL Diagnostics) use somewhat different antigens and likely provide a more specific (and possibly more reliable) diagnosis of APS while retaining good-to-excellent sensitivity. Other tests, such as ELISA for prothrombin antibodies and annexin V antibodies, are still undergoing development and will require standardization and extensive evaluation. We thank Dr Isabel Abreu and Dr Mittermeyer B. Santiago for performing some of the studies reported in this review.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219246     DOI: 10.1097/00003081-200103000-00007

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  4 in total

1.  Antiphospholipid syndrome accompanied by a silent splenic infarct in a patient with juvenile SLE.

Authors:  Tamás Constantin; Andrea Ponyi; Edit Varga; Katalin Dankó; György Fekete; Gábor Kovács
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

Review 2.  Recent advances in the diagnosis of antiphospholipid syndrome.

Authors:  Hyun-Sook Chi
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 3.  Antiphospholipid antibodies in pediatrics.

Authors:  Ana I Quintero-Del-Rio
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

4.  Recurrent intestinal perforations as a presentation of antiphospholipid syndrome.

Authors:  Saleh Al-Daqal; Majed Mansouri; Mohammed H Qari; Abdulrahman Sibiany
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.